2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- 18.00%1-Year Change
- Medical DevicesIndustry
ALR Tech SG (ALRTF)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 36
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
ALR TECHNOLOGIES TO RELAUNCH THE GLUCURVE PET CGM IN JANUARY 2026
ALR Technologies SG Ltd plans to relaunch its GluCurve Pet CGM, a continuous glucose monitoring system for cats and dogs, in the Canadian market in January 2026, with potential expansion to other global markets in early 2026.
12/08/2025, 9:14 AM • Benzinga
Peers
Statistics
MoreInformation as of 06/03/2026
Company Profile
ALR Technologies SG Ltd., a data management company, provides diabetes care management solutions for human and animal health diabetes. It offers ALRT Diabetes Solution, a diabetes care that includes a diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The company also provides GluCurve Pet CGM, a solution to address an unmet need in diabetes care for felines and canines by combining the hardware of a CGM with the software of an adapted version of diabetes solution product for use by veterinarians in animal health. The company sells its products directly and through distributors in the United States, Brazil, the United Kingdom, European Union, and internationally. The company was incorporated in 1987 and is based in Singapore.
Key Executives
- Sidney S. Chan
- Christine Y. S. Kan
- Benjamin Szeto
- Steven Brassard
- Jacqueline Wu
Current Ownership Distribution
- Other631.6M (97.85%)
- Insiders13.9M (2.15%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)